Purdue sues Teva to block OxyContin challenge

08-04-2014

Purdue sues Teva to block OxyContin challenge

Photo: librakv / Shutterstock.com

OxyContin (oxycodone hydrochloride) maker Purdue Pharma has filed suit against Teva to stop the generic drug maker trying to litigate claims to a patent for which it had filed a Paragraph III certification.


Purdue, Teva, OxyContin, Paragraph III, US District Court for the Southern District of New York

LSIPR